cervical cancer screening
cervical omics
Female cancer prediction
cervical smear
prevention of female cancers
female specific cancers
invasive cancer
cancer development
abundant cervical cells
multi-omics
individual’s risk
proposed cervical cell omics analysis method
personalised screening
omics technologies
risk prediction tool’s output
prevention strategy
risk-benefit communication
identification of high risk individuals
decision analysis
analysis pipeline
epigenome
consortium
personalised recommendations
clinical oncology
health economics
clinical practice
public health
cell of origin
direct interaction
multi-disciplinary team of experts
excellent non-invasive source of high quality DNA
interventions
infection
ideal window
implementation
causal agent
rapid translation
preventive
P4 Medicine
test
stakeholder groups
behavioural issues
lifetime
halt progression
availability
breast
tandem
human papilloma virus
various hormonal conditions
novel concept
significant progress
exciting opportunity
recording
Europe
metagenome
effectiveness
accessibility
recent years
hormone sensitive
FORECEE project
readout
environmental exposure
Müllerian tract